Editas Medicine (EDIT) Long-Term Investments (2020 - 2024)
Editas Medicine's Long-Term Investments was $39.2 million in Q2 2024, down 18.5% from $48.1 million a year earlier and down 51.4% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Long-Term Investments (2020 - 2024) Analysis & Trends
At the end of FY2023, Long-Term Investments at Editas Medicine came in at $104.02 million, up 11.7% from FY2022.
- Long-Term Investments shows a three-year compound annual growth rate of -1.7% (FY2020 to FY2023).
- In earlier years, Long-Term Investments was $93.1 million in FY2022 (-22.5%), $120.07 million in FY2021 (+9.5%) and $109.66 million in FY2020.
- The Q2 2024 figure marks the lowest quarterly Long-Term Investments in data going back to Q3 2020.
- Compared with a year earlier, Long-Term Investments was higher in three of the last eight quarters, with an average decline of 4.7%.
- The best year-over-year quarter for Long-Term Investments over five years was Q3 2021 (growth of 115.7%); the worst was Q3 2022 (a decline of 40.7%).
- Per Business Quant data, EDIT's Long-Term Investments in the three quarters before Q2 2024 was $80.61 million (Q1 2024), $104.02 million (Q4 2023) and $96.8 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,168.43 Bn | 1,137.01 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 647.59 Bn | 567.45 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.21 Bn | 476.32 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 366.30 Bn | 320.68 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 303.04 Bn | 267.03 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.68 Bn | 241.37 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 242.11 Bn | 197.51 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.85 Bn | 169.05 Bn | 6.22 Bn | - |
| 9 | Pfizer | 173.11 Bn | 119.75 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Editas Medicine | 222.07 Mn | -489.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 80.61 Mn |
| Dec 31, 2023 | 104.02 Mn |
| Sep 30, 2023 | 96.80 Mn |
| Jun 30, 2023 | 48.10 Mn |
| Mar 31, 2023 | 83.34 Mn |
| Dec 31, 2022 | 93.10 Mn |
| Sep 30, 2022 | 58.84 Mn |
| Jun 30, 2022 | 75.10 Mn |
| Mar 31, 2022 | 78.05 Mn |
| Dec 31, 2021 | 120.07 Mn |
| Sep 30, 2021 | 99.20 Mn |
| Jun 30, 2021 | 87.60 Mn |
| Mar 31, 2021 | 97.90 Mn |
| Dec 31, 2020 | 109.66 Mn |
| Sep 30, 2020 | 46.00 Mn |
API Access
Editas Medicine Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();